Aberrantly hypermethylated genes in human lung cancers were searched for by a genome scanning technique, methylation-sensitive-representational dierence analysis (MS-RDA). A total of 59 DNA fragments were isolated as those methylated more heavily in either/both of two lung squamous cell carcinoma cell lines, EBC-1 and LK-2, than in a primary culture of normal human bronchial epithelium, NHBE. Thirty-four DNA fragments, whose hypermethylation was con®rmed in primary squamous cell carcinomas, were sequenced. By database searches, 17 of them were shown to be located within 2 kb of putative CpG islands, and ®ve of the 17 DNA fragments had transcribed regions of known genes in their vicinities. By RT ± PCR of the ®ve genes in the carcinoma cell lines and NHBE, decreased expression of HTR1B (5-hydroxytryptamine receptor 1B) and EDN1 (endothelin-1) was observed. Sequencing after bisul®te modi®ca-tion showed that the CpG island in the promoter region of HTR1B was hypermethylated, while that of EDN1 was not. Demethylation and re-expression of HTR1B were observed after treatment of LK-2 cells with 5-aza-2'-deoxycytidine. In primary lung cancers, decreased mRNA expression of HTR1B was observed in 11 of 20 cases, and that of EDN1 was in 16 of 20 cases. Immunohistochemical analysis of endothelin-1 con®rmed that its immunoreactivity was reduced in squamous cell carcinoma cells compared with that in normal bronchial epithelial cells. Considering that endothelin-1 induces apoptosis in melanoma cells and that silencing of endothelin receptor B is observed in prostate cancers, its reduced expression was speculated to confer a growth advantage to lung cancer cells. MS-RDA was shown to isolate DNA fragments that are hypermethylated and silenced, such as HTR1B, and those whose expressions are altered and the methylation statuses outside the promoter region are altered, such as EDN1. Oncogene (2001) 20, 7505 ± 7513.
Introduction
Lung cancer is one of the major causes of cancer death in many countries. Both genetic and epigenetic alterations have been identi®ed as components of alterations involved in multistep lung carcinogenesis. Mutations of the ras, p53 and RB genes are found in approximately 15 ± 20, 40 ± 60 and 15 ± 30%, respectively, of human non-small cell lung cancers (NSCLCs) (Sekido et al., 1998) . Hypermethylation and transcriptional repression of the p16 and HIC-1 (hypermethylated in cancer) genes have been reported in 28 and 33% of NSCLCs (Eguchi et al., 1997; Merlo et al., 1995) . However, when the necessity of multiple alterations for the development of a cancer is taken into account, a signi®cant portion of genetic alterations involved in NSCLCs still remains unknown. Considering that hypermethylation of various genes plays wide roles in various human cancers (Baylin et al., 1998; Jones and Laird, 1999; Sugimura and Ushijima, 2000) , it can be hypothesized that there will be more genes that are involved in NSCLCs by their hypermethylation and silencing.
To scan the genome for such genes, we previously established the methylation-sensitive-representational dierence analysis (MS-RDA) method (Ushijima et al., 1997) . In this method, the whole genome is represented by DNA fragments (HpaII-amplicon) derived from unmethylated CpG-rich regions. This is accomplished by the digestion of genomic DNA with HpaII, which recognizes the 5'-CCGG-3' sequence and is blocked by methylation of the internal C residue, followed by ampli®cation of the total digestion product by PCR after ligation of a universal adaptor. When a speci®c genomic region is aberrantly methylated in a cancer, DNA fragments derived from the region are absent in the HpaII-amplicon from the cancer, though they are present in the HpaII-amplicon from the normal counterpart. A series of subtractive hybridizations between the two HpaII-amplicons are known to reveal DNA fragments derived from the aberrantly methylated region. The MS-RDA method was recently shown to be capable of identifying all the known imprinted regions on mouse distal chromosome 2 (Kelsey et al., 1999) .
In this study, to identify genes aberrantly hypermethylated and transcriptionally silenced in NSCLCs, we performed modi®ed MS-RDA using two squamous lung cancer cell lines and normal human bronchial epithelial cells, considering that squamous cell carcinomas arise from the bronchial epithelia (Harris et al., 1991; Sekido et al., 1998) .
Results

Isolation of DNA fragments hypermethylated in human lung cancers
Two series of MS-RDA were performed, using NHBE as the tester and either of human squamous cell lung cancer cell lines, EBC-1 or LK-2, as the driver. A total of 96 clones, 48 clones from each subtraction, were analysed for their independence by cross-hybridization, and 66 of them were found to be independent. The 66 clones were further analysed by Southern blot whether or not they really detected dierential methylation in the carcinoma cell lines. Fifty-nine clones were found to detect hypermethylation, four clones detected polymorphisms, and three clones were not dierentially methylated in the tester and the drivers. To exclude arti®cial hypermethylation during the establishment of the cell lines, the 59 DNA fragments were examined for their methylation status in ®ve primary squamous cell carcinomas. Thirty-four clones were shown to be hypermethylated in two or more clinical samples by Southern blot analysis using HpaII (Table 1) .
Identification of genes with decreased expression
These 34 dierentially methylated DNA fragments were sequenced, and, by GenBank searches, thē anking genomic sequences were identi®ed for 30 fragments. Seventeen of them had CGIs (GardinerGarden and Frommer, 1987; Larsen et al., 1992) in their 2 kb vicinities (Table 1) , and ®ve had known genes in their vicinities (Figure 1 ). Fragment B3 was derived from intron 1 of Endothelin-1 (EDN1); D3 from exon 1 of Protocadherin g-a12 (PCDHGA12); F12 from exon 5 of Myeloid ecotropic viral integration site 1 (MEIS1); G4 from exon 1 of Collagen12-a1 (COL12A1); and H6 from the upstream region of 5-Hydroxytryptamine receptor 1B (HTR1B). The expression levels of these ®ve genes were analysed by RT ± PCR using NHBE and the two carcinoma cell lines, and those of EDN1 and HTR1B were found to be decreased in carcinoma cell lines.
Transcriptional silencing of HTR1B in carcinoma cell lines DNA fragment H6 was located 3 kb upstream of an intronless gene, HTR1B (Demchyshyn et al., 1992) . The DNA fragment was completely methylated in two cancer cell lines while it was demethylated in NHBE ( Figure 2a ). HTR1B expression was completely lost in EBC-1 and LK-2 cell lines (Figure 2b ). The putative CGI 900 bp upstream of the translation initiation site of the HTR1B gene (HTR1B-Pro in Figure 2c ; the transcriptional start site is unknown) and a CpG-rich region within the fragment H6 (HTR1B-H6) were sequenced after bisul®te modi®cation. The HTR1B-Pro region was almost completely methylated in LK-2 and EBC-1, while it was demethylated in NHBE ( Figure  2c ). The HTR1B-H6 region was almost completely methylated in the two carcinoma cell lines, while it was partially demethylated in NHBE (Figure 2c) . To examine the role of the hypermethylation in the loss of HTR1B expression, LK-2 cells were treated with a demethylating agent, 5-aza-2'-deoxycytidine (5-aza-dC). After the treatment, it was observed that the H6 fragment was demethylated and expression of HTR1B were restored (Figure 2d ,e). From these ®ndings, the hypermethylation of the CGI in the upstream region of HTR1B was considered to be playing a causal role in the loss of its expression.
Decreased expression of EDN1 in carcinoma cell lines
The DNA fragment B3 was located in the junction of intron 1 and exon 2 of EDN1. The DNA fragment was completely methylated in EBC-1 and LK-2 cell lines, while it was demethylated in NHBE ( Figure 3a) . EDN1 expression was partially and completely lost in EBC-1 and LK-2, respectively ( Figure 3b) . A putative CGI 200 bp upstream of the transcriptional initiation site of the EDN1 gene (EDN-Pro in Figure 3c ) and a CpGrich region in intron 1 (EDN-B3) were sequenced after bisul®te modi®cation. The CGI was not methylated in any of NHBE, EBC-1 and LK-2 (Figure 3c ). On the other hand, the EDN-B3 region was completely methylated in EBC-1 and LK-2 while it was demethylated in NHBE.
Reduced expression of HTR1B and EDN1 in primary lung cancers
To exclude artifacts only observed in cell lines, the methylation status of the DNA fragments and expression levels of HTR1B and EDN1 were examined in primary human lung cancers and the corresponding normal tissues. Since the primary normal lung tissue consisted of cells of various origins and primary cancer samples had contaminating stromal cells, an increase in the proportion of methylated DNA molecules and decrease of expression levels were taken as positive ( Figure 4 ). The DNA fragment H6 was hypermethylated in 14 of 20 primary cancers, and decreased HTR1B expression was observed in 11 of 20 (Table 2 ). The DNA fragment B3 was hypermethylated in 14 of 20 primary cancers, and decreased EDN1 expression was observed in 16 of 20 (Table 2) .
Immunohistochemistry of endothelin-1, an antibody against which was available, was performed to con®rm that it was expressed in normal alveolar and bronchial epithelial cells and reduced in cancer cells. Immunoreactivity of endothelin-1 was strongly positive in the (Figure 5d ), as previously reported (Ehrenreich et al., 1990; Markewitz et al., 1995; Mattoli et al., 1990) . In all the three cases (cases 1, 3 and 8), immunoreactivity was absent in carcinoma cells (Figure 5e ).
Discussion
Two genes were identi®ed as those whose expressions were decreased in human lung carcinoma cell lines and primary cancers. In the case of HTR1B, CGI in its promoter region was methylated in LK-2 and EBC-1, and its expression was restored by treatment with azadC. The methylation of the upstream region of the transcription start site is known to block transcription signi®cantly (Baylin et al., 1998) , and these facts strongly indicated that HTR1B gene was silenced by the promoter hypermethylation at least in the two carcinoma cell lines. As for the role of HTR1B silencing in lung carcinogenesis, little is known, including its distribution in air-way systems. It is of great interest to examine the role of shut-o of 5-hydroxytryptamine (serotonin) and its signaling from its type B receptor. In the case of EDN1, the CGI in its promoter region was not methylated in two carcinoma cell lines. On the other hand, methylation in intron 1, where no CGI was present, was observed in the two carcinoma cell lines while it was absent in NHBE. EDN1 mRNA expression was lost in LK-2 and moderately decreased in EBC-1. Considering that methylation of gene body and introns can be involved in the regulation of gene expression (Costello et al., 1994; Sengupta and Smith, 1998) , the role of the methylation of EDN1 intron 1 in its decreased expression cannot be concluded at this stage. Decreased expression was also observed in the primary cancers (16/20; 80%), but correlation between the decreased expression and methylation of intron 1 was not clear. Endothelin-1 was originally identi®ed as a potent vasoconstrictive peptide (Yanagisawa et al., 1988) , and subsequent studies revealed its diverse biological roles (Masaki et al., 1992) . A recent study showed that endothelin-1 induces apoptosis of human melanoma cells and inhibits their growth (Okazawa et al., 1998) . This signal is mediated by endothelin (Okazawa et al., 1998) . Hypermethylation of the 5' CGI of the ETRB gene and its decreased expression have been reported in human prostate cancers (Nelson et al., 1996 (Nelson et al., , 1997 . These reports and our ®ndings suggest that endothelin-1 and ETRB may mediate apoptotic signals also in bronchial epithelium, and that inactivation of this signaling pathway may help the bronchial epithelial cells escape from apoptosis and play a role in lung carcinogenesis.
In the clinical sample analysis, hypermethylation of HTR1B and its decreased expression did not correlate clearly, in spite that correlation was clear in the cell lines and re-expression by aza-dC was observed in LK-2 cells. In clinical samples, the presence of contaminating non-cancerous cells in cancer samples and the diverse origins of cells in the normal samples should be considered. Especially, although NHBE is supposed to be the normal counterpart of lung cancers (Al Moustafa et al., 1999; Jakowlew et al., 1997; Moghal and Neel, 1998) , there still remains a possibility that lung cancers are originated from a minor population of cells in the lung, dierent from NHBE, and that the population has a methylated 5' CGI for the HTR1B gene. If this were the case, analysis of methylation patterns in various cell types would greatly facilitate clari®cation of the origin of cancer cells. For this purpose, development of a technique capable of in situ Figure 2 Silencing of HTR1B by its promoter hypermethylation in the carcinoma cell lines. (a) Methylation status of DNA fragment H6 isolated by MS-RDA. Each genomic DNA from NHBE and two carcinoma cell lines was digested with HpaII or MspI, and hybridized with DNA fragment H6 (388 bp). The fragment H6 was completely methylated in the two carcinoma cell lines (lanes 2 and 3) while it was completely demethylated in NHBE (lane 1). (b) Expression levels of HTR1B analysed by RT ± PCR. HTR1B expression was completely lost in EBC-1 and LK-2. (c) Methylation status of the HTR1B-H6 region and the CGI in the HTR1B promoter region. The fraction of methylated DNA molecules at each CpG site is shown by the proportion of ®ll in each circle. The CGI in the HTR1B promoter region was almost completely methylated in LK-2 and EBC-1 while it was almost completely demethylated in NHBE. HTR1B-H6 region was relatively hypermethylated in the two carcinoma cell lines, compared with NHBE. (d) Demethylation of DNA fragment H6 by 5-aza-dC treatment. LK-2 cells were treated with 5-aza-dC twice for 24 h. Methylation status of genomic DNA was analysed by Southern blot hybridization after digestion with HpaII, and appearance of an unmethylated band (388 bp) was observed after 5-aza-dC treatment. (e) Induction of HTR1B expression by 5-azadC. RT ± PCR showed that HTR1B was re-expressed after 5-azadC treatment (Nuovo et al., 1999) , is important. In addition, there is a possibility that the H9 fragment was not exactly located in the region that was critical for transcriptional control and would show better correlation.
MS-RDA isolated 17 DNA fragments¯anked by CGIs. Since the methylation status of the¯anking CGI was also altered for one of the two genes analysed in this study, a signi®cant proportion of the 17 CGIs will have altered methylation status. Identi®cation of genes whose expressions are silenced by the hypermethylation is expected to lead to identi®cation of new tumorsuppressors. It is noteworthy that recent public access to the human genome draft sequence greatly facilitated the power of MS-RDA by enabling us to identify CGIs and genes¯anking the DNA fragments isolated by MS-RDA.
Materials and methods
Cell lines and tissue samples
Normal human bronchial epithelial cells (NHBE) were purchased from Clonetics (Walkersville, MD, USA). Two human lung squamous cell carcinoma cell lines (EBC-1, LK-2) were obtained from the Japanese Collection of Research Bio-resources. Twenty pairs of a primary lung cancer and adjacent non-cancerous lung tissue were obtained from 15 male and ®ve female patients (average: 63.9 years old) with informed consent. DNA was extracted by standard phenol/ chloroform procedures (Sambrook, 2000) . RNA was isolated using ISOGEN (Nippon gene, Tokyo, Japan).
Modified MS-RDA
To enrich the DNA fragments derived from CpG islands (CGIs), we modi®ed the original method of MS-RDA (Ushijima et al., 1997) . Genomic DNA of the tester and driver were digested by HpaII (New England Biolabs, Beverly, MA, USA), and then fractionated by reverse electrophoresis (Kadokami and Lewis, 1995) to enrich DNA fragments shorter than 500 bp (tester) and those shorter than 600 bp (driver). The RHpa adaptor was ligated to the fractionated tester and driver DNA, and HpaII- Figure 4 Methylation and expression of HTR1B and EDN1 in primary lung cancers. (a,c) Southern blot analysis of DNA from pairs of normal adjacent tissues (N) and primary lung cancers (Ca) after digestion with HpaII (H) or MspI (M). Hybridization was performed with DNA fragment H6 (388 bp) for HTR1B (a), and with DNA fragment B3 (414 bp) for EDN1 (c). Reduction of the hybridization signal (closed arrow heads) in HpaII digest in a cancer sample, compared with that in a normal sample, was taken as hypermethylation of the respective DNA fragments. The appearance of hypermethylated bands (open arrow heads) was also taken into account. Hypermethylation of H6 was observed in cases 1 and 4, and that of B6 was in cases 1, 3 and 4. Sq: squamous cell carcinoma. (b,d) Expression levels of HTR1B and EDN1 were examined by RT ± PCR. Decreased expression of HTR1B was observed in cases 1, 2 and 3. That of EDN1 was in cases 1, 3 and 4 amplicon was prepared by PCR in the presence of 1 M betaine (Sigma, St. Louis, MO, USA), which facilitated ampli®cation of G+C rich sequences (Henke et al., 1997; McDowell et al., 1998) . The RHpa adaptor of the tester HpaII-amplicon was switched to the JHpa adaptor, and the RHpa adaptor of the driver HpaII-amplicon was removed by MspI digestion and gel ®ltration. The tester HpaII-amplicon was mixed with an excess amount of the driver HpaIIamplicon, and competitive hybridization was performed. Then, PCR with the JHpa primer was performed in the presence of 1 M betaine. The products after two cycles of competitive hybridization were cloned into the pGEM-T Easy vector (Promega, Madison, WI, USA). After transformation, insert-positive clones were selected by PCR using Sp6 and T7 primers. Clones were dot-blotted, and crosshybridization was performed with the above PCR products after removing the adaptor and plasmid portions.
Southern blot analysis
Two mg DNA was digested with 20 units of HpaII or MspI (New England Biolabs). Puri®ed DNA was eletrophoresed in a 1% agarose gel, and transferred to a Nylon membrane (Hybond N+; Amersham-Pharmacia Biotech, Uppsala, Sweden) and UV-cross linked. The membranes were hybridized and denatured probes prepared by Gene Images Random Prime Labeling Kit (Amersham-Pharmacia Biotech). The hybridization was detected by a Gene Images CDP-Star detection kit (Amersham-Pharmacia Biotech).
DNA sequencing and database search
Cycle-sequencing was performed with a BigDye Terminator kit (Applied Biosystems, Foster City, CA, USA) using an ABI 310 automated DNA sequencer (Applied Biosystems). Repetitive sequences were screened by the Repeat Masker Web site (University of Washington Genome Center, http:// ftp.genome.washington.edu/cgi-bin/RepeatMasker), and sequence homology was searched for by the BLASN algorithm.
RT ± PCR analysis
cDNA was synthesized by a Superscript II kit (Life Technologies, Rockville, MD, USA) using 1 mg of total 
Sodium bisulfite modification and sequencing
According to the protocol by Rein et al. (1997) , 1 mg of DNA was incubated with 0.6 N NaOH in a ®nal volume of 20 ml for 15 min at 378C. One hundred and twenty microliters of a solution containing 3.6 M sodium bisul®te (freshly prepared, Sigma) and 0.6 mM hydroquinone (freshly prepared, Sigma) was added, and the sample underwent 20 cycles of denaturation of 958C for 30 s and incubation at 508C for 15 min. The sample was desalted using the Wizard DNA Clean-Up System, and desulfonated by incubation with 0.6 N NaOH for 5 min at room temperature. The DNA was ethanol-precipitated and re-suspended in 10 ml of H 2 O. Using 1 ml of the solution, each region was ampli®ed with the following primers and conditions (product length, annealing temperature, number of cycles). HTR1B-H6 (195 bp, 608C, 40 cycles), S: 5'-ATT TGT TTG GAG GTT TTT TTT AG-3', A: 5'-TTC CTT TCT CAC TTT AAA ACA CA-3'. HTR1B-Pro (244 bp, 558C, 40 cycles), S: 5'-GGA GTT TTT TTG GTT AGG AAA GG-3'; A: 5'-CGA CAC ACT AAA AAA AAA CAA AT-3'. EDN1-Pro (234 bp, 558C, 40 cycles), S: 5'-CGG GGT TGG TAG TTT GTA AAG GG-3'; A: 5'-CGA CTT TAT TCC AAC CCC AAA CA-3'. EDN1-B6 (173 bp, 608C, 40 cycles), S: 5'-TTT ATT TGT GTT GGG AGG GGA GT-3'; A: 5'-CAC ATT CCA AAA TTT TCA TTC CC-3'. The PCR product was cloned into pGEM-T Easy, and used as a template for cycle sequencing. The proportion of methylated cytosine was determined after sequencing 10 clones.
5-aza-dC treatment
LK-2 cells were seeded at a density of 1610 5 cells/10 cm plate on day 0, and exposed to 5 mM 5-aza-dC (Sigma) for 24 h on days 3 and 5. The cells were cultured in a fresh media after each treatment, and harvested on day 8.
Immunohistochemistry
Deparanized sections were treated by microwave, and endogenous peroxidase was inactivated by 0.3% hydrogen peroxide. Mouse monoclonal antibody against the carboxyl terminal of human endothelin-1 (Yamasa Soy Sauce, Choshi, Japan) was used for the primary antibody in a dilution of 1:200 in 1% normal horse serum in PBS. Mouse IgG1 (DAKO, Copenhagen, Denmark) was used as a negative control in a dilution of 1:100. The primary antibody was detected by anti-mouse IgG antibody conjugated with biotin, using a Vectastain ABC peroxidase staining kit (Vector Laboratories, Burlingame, CA, USA) and diaminobenzidine tetrahydrochloride as the chromogen. Slides were counterstained with Mayer's hematoxylin.
